Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Conservative Therapy | Research

Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana

Authors: Perditer Okyere, Isaac Okyere, Grace Essuman, Joseph Attakora, Dorcas Serwaa, Irene Esi Donkoh, Richard K.D. Ephraim

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

The incidence of end stage kidney disease (ESKD) is increasing in Ghana as with the rest of the world. This study compared the sociodemographic, diagnostic characteristics (clinical, biochemical and imaging) and clinical outcomes of ESKD patients who chose either renal replacement therapy (RRT) or conservative therapy as well as the factors that influenced their choice.

Methods

We retrospectively reviewed the records of 382 ESKD patient from 2006 to 2018. The data was collected from the Nephrology Clinic at the Komfo Anokye Teaching Hospital (KATH). Sociodemographic, diagnostic (clinical, biochemical and imaging) and therapeutic data were obtained, organized and analyzed with Statistical Package for the Social Sciences (SPSS).

Results

Of the 382 patients, 321 had conservative therapy whiles 61 had renal replacement therapy. The mean age of participants was 47.71 ± 16.10 years. Bipedal swelling (16.8%), fatigue (10.4%) and facial swelling (9.2%) were the major clinical features. Chronic glomerulonephritis (31.4%), hypertension (30.3%) and diabetes mellitus nephropathy (28.2%) were the most frequent predisposing conditions. Nifedipine (82.0%), bisoprolol (32.8%), aspirin (19.7%), ranitidine (26.2%), metformin (13.1%) and lasix (78.7%) were commonly used by the RRT patients than their conservative therapy counterparts. Compared to their RRT counterparts, patients on conservative therapy were more on irbesartan/lisinopril (57.9%) and sodium hydro carbonate (NaHCO3) (52.0%). Diastolic blood pressure (DBP) (p = 0.047), uremic gastritis (p = 0.007), anaemia, uraemia, haematuria and hyperkalaemia (p < 0.001) were more common in conservative therapy patients than RRT patients with RRT patients showing better corticomedullary differentiation (38.1% vs. 27.7%, p < 0.001) and normal echotexture (15.0% vs. 11.6%, p = 0.005). Age, gender, occupation and duration of illness were significantly associated with the decision to opt for conservative therapy.

Conclusion

Patients on conservative therapy have worse clinical outcomes than their RRT counterparts. Early referrals to nephrologist as well as subsidized RRT should be targeted.
Literature
1.
go back to reference Amoako YA, Laryea DO, Bedu-Addo G, Andoh H, Awuku YA. Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. Pan Afr Med J. 2014;18. Amoako YA, Laryea DO, Bedu-Addo G, Andoh H, Awuku YA. Clinical and demographic characteristics of chronic kidney disease patients in a tertiary facility in Ghana. Pan Afr Med J. 2014;18.
2.
go back to reference Antwi S. State of renal replacement therapy services in Ghana. Blood Purif. 2015;39(1–3):137–40.CrossRefPubMed Antwi S. State of renal replacement therapy services in Ghana. Blood Purif. 2015;39(1–3):137–40.CrossRefPubMed
3.
go back to reference Kakitapalli Y, Ampolu J, Madasu SD. S SKML. Detailed Review of Chronic Kidney Disease. 2020;85–91. Kakitapalli Y, Ampolu J, Madasu SD. S SKML. Detailed Review of Chronic Kidney Disease. 2020;85–91.
4.
go back to reference Bear RA, Stockie S. Patient engagement and patient-centred care in the management of advanced chronic kidney disease and chronic kidney failure. 2014;1–8. Bear RA, Stockie S. Patient engagement and patient-centred care in the management of advanced chronic kidney disease and chronic kidney failure. 2014;1–8.
5.
go back to reference Orlandi PF, Fujii N, Roy J, Chen HY, Lee Hamm L, Sondheimer JH, et al. Hematuria as a risk factor for progression of chronic kidney disease and death: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol. 2018;19(1):1–11.CrossRef Orlandi PF, Fujii N, Roy J, Chen HY, Lee Hamm L, Sondheimer JH, et al. Hematuria as a risk factor for progression of chronic kidney disease and death: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol. 2018;19(1):1–11.CrossRef
6.
go back to reference Ruiz-Arenas R, Sierra-Amor R, Seccombe D, Raymondo S, Graziani MS, Panteghini M, et al. A summary of worldwide national activities in Chronic Kidney Disease (CKD) testing. Ejifcc. 2017;28(4):302.PubMedPubMedCentral Ruiz-Arenas R, Sierra-Amor R, Seccombe D, Raymondo S, Graziani MS, Panteghini M, et al. A summary of worldwide national activities in Chronic Kidney Disease (CKD) testing. Ejifcc. 2017;28(4):302.PubMedPubMedCentral
7.
go back to reference Hood SA, Sondheimer JH. Impact of Pre-ESRD Management on Dialysis Outcomes: A Review. 1993. Hood SA, Sondheimer JH. Impact of Pre-ESRD Management on Dialysis Outcomes: A Review. 1993.
9.
go back to reference Sumida K, Kovesdy CP. Disease Trajectories Before ESRD_ Implications for Clinical Management. Semin Nephrol. 2017;37(2):132–43.CrossRefPubMed Sumida K, Kovesdy CP. Disease Trajectories Before ESRD_ Implications for Clinical Management. Semin Nephrol. 2017;37(2):132–43.CrossRefPubMed
10.
go back to reference Hynes DM, Stroupe KT, Kaufman JS, Reda DJ, Peterman A, Browning MM, et al. Adherence to Guidelines for ESRD Anemia Management. 2006;47(3):455–61. Hynes DM, Stroupe KT, Kaufman JS, Reda DJ, Peterman A, Browning MM, et al. Adherence to Guidelines for ESRD Anemia Management. 2006;47(3):455–61.
11.
go back to reference Weigert A, Drozdz M, Silva F, Frazão J, Alsuwaida A, Krishnan M, et al. Influence of gender and age on haemodialysis practices: A European multicentre analysis. Clin Kidney J. 2019;13(2):217–24.CrossRefPubMedPubMedCentral Weigert A, Drozdz M, Silva F, Frazão J, Alsuwaida A, Krishnan M, et al. Influence of gender and age on haemodialysis practices: A European multicentre analysis. Clin Kidney J. 2019;13(2):217–24.CrossRefPubMedPubMedCentral
12.
go back to reference Carson RC, Juszczak M, Davenport A, Burns A. Is Maximum Conservative Management an Equivalent Treatment Option to Dialysis for Elderly Patients with Significant Comorbid Disease ?:1611–9. Carson RC, Juszczak M, Davenport A, Burns A. Is Maximum Conservative Management an Equivalent Treatment Option to Dialysis for Elderly Patients with Significant Comorbid Disease ?:1611–9.
13.
go back to reference Williams B, Mcdaid R, Walker R, Quarterly R, Cross J, Burns A. Maximum Conservative Management of End Stage Renal Failure. What Can Patients and Their Families Expect? In: Conference abstract—The Renal Association Annual Conference London: October. 2002. Williams B, Mcdaid R, Walker R, Quarterly R, Cross J, Burns A. Maximum Conservative Management of End Stage Renal Failure. What Can Patients and Their Families Expect? In: Conference abstract—The Renal Association Annual Conference London: October. 2002.
14.
go back to reference Britain) NCC for CC (Great. Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care. In Royal College of Physicians; 2008. Britain) NCC for CC (Great. Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care. In Royal College of Physicians; 2008.
15.
go back to reference Tamura MK, Meier DE. Commentary Five Policies to Promote Palliative Care for Patients with ESRD. 2013;1783–90. Tamura MK, Meier DE. Commentary Five Policies to Promote Palliative Care for Patients with ESRD. 2013;1783–90.
16.
go back to reference Tamura MK, Hare AMO, Lin E, Holdsworth LM, Malcolm E, Moss AH. Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care. Am J Kidney Dis. 2018;71(6):866–73.CrossRefPubMedCentral Tamura MK, Hare AMO, Lin E, Holdsworth LM, Malcolm E, Moss AH. Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care. Am J Kidney Dis. 2018;71(6):866–73.CrossRefPubMedCentral
17.
go back to reference Rak A, Raina R, Suh TT, Krishnappa V, Darusz J, Sidoti CW, et al. Palliative care for patients with end-stage renal disease: approach to treatment that aims to improve quality of life and relieve suffering for patients (and families) with chronic illnesses *. 2017;10(1):68–73. Rak A, Raina R, Suh TT, Krishnappa V, Darusz J, Sidoti CW, et al. Palliative care for patients with end-stage renal disease: approach to treatment that aims to improve quality of life and relieve suffering for patients (and families) with chronic illnesses *. 2017;10(1):68–73.
18.
go back to reference Davison SN. Ethics Series The Ethics of End-of-Life Care for Patients with ESRD. 2012;2049–57. Davison SN. Ethics Series The Ethics of End-of-Life Care for Patients with ESRD. 2012;2049–57.
19.
go back to reference Morton RL, Webster AC, Mcgeechan K, Howard K, Murtagh FEM, Gray NA, et al. Article Conservative Management and End-of-Life Care in an Australian Cohort with ESRD. 2016;2195–203. Morton RL, Webster AC, Mcgeechan K, Howard K, Murtagh FEM, Gray NA, et al. Article Conservative Management and End-of-Life Care in an Australian Cohort with ESRD. 2016;2195–203.
20.
go back to reference State O. The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria : Is there a change in trend ? 2011;11(4). State O. The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria : Is there a change in trend ? 2011;11(4).
21.
go back to reference Dialysis FOF. Hemodialysis. Management problems in developing countries. with Nigeria as a surrogate. 2003;63:93–5. Dialysis FOF. Hemodialysis. Management problems in developing countries. with Nigeria as a surrogate. 2003;63:93–5.
22.
go back to reference Davison SN, Sc M. The Prevalence and Management of Chronic Pain. 2007;10(6). Davison SN, Sc M. The Prevalence and Management of Chronic Pain. 2007;10(6).
23.
go back to reference Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144(7):475–84.CrossRefPubMedPubMedCentral Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144(7):475–84.CrossRefPubMedPubMedCentral
24.
go back to reference Ishikawa I, Maeda K, Nakai S, Kawaguchi Y. Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;35(6):1072–5.CrossRefPubMed Ishikawa I, Maeda K, Nakai S, Kawaguchi Y. Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;35(6):1072–5.CrossRefPubMed
25.
go back to reference Education M. End-stage renal disease in India and Pakistan: Burden of disease and management issues. 2003;63:115–8. Education M. End-stage renal disease in India and Pakistan: Burden of disease and management issues. 2003;63:115–8.
26.
go back to reference Momoniat T, Ilyas D, Bhandari S. ACE inhibitors and ARBs: Managing potassium and renal function. Cleve Clin J Med. 2019;86(9):601–7.CrossRefPubMed Momoniat T, Ilyas D, Bhandari S. ACE inhibitors and ARBs: Managing potassium and renal function. Cleve Clin J Med. 2019;86(9):601–7.CrossRefPubMed
27.
go back to reference Lee H-Y, Shin J, Kim G-H, Park S, Ihm S-H, Kim HC, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25(1):20.CrossRefPubMedPubMedCentral Lee H-Y, Shin J, Kim G-H, Park S, Ihm S-H, Kim HC, et al. 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. 2019;25(1):20.CrossRefPubMedPubMedCentral
28.
go back to reference Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Wyck DV, Bunnapradist S, Horwich TB. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation [Internet]. 2009;119(5):671–9. [cited 2016 Mar 18].CrossRef Kalantar-Zadeh K, Regidor DL, Kovesdy CP, Wyck DV, Bunnapradist S, Horwich TB. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation [Internet]. 2009;119(5):671–9. [cited 2016 Mar 18].CrossRef
29.
go back to reference Lindberg M, PRÜTZ K, Lindberg P, Wikström B. Interdialytic weight gain and ultrafiltration rate in hemodialysis: lessons about fluid adherence from a national registry of clinical practice. Hemodial Int. 2009;13(2):181–8.CrossRefPubMed Lindberg M, PRÜTZ K, Lindberg P, Wikström B. Interdialytic weight gain and ultrafiltration rate in hemodialysis: lessons about fluid adherence from a national registry of clinical practice. Hemodial Int. 2009;13(2):181–8.CrossRefPubMed
30.
go back to reference Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007;11(1):21–31.CrossRefPubMed Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007;11(1):21–31.CrossRefPubMed
31.
go back to reference Verberne WR, Dijkers J, Kelder JC, Geers ABM, Jellema WT, Vincent HH, et al. Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: A cohort study. BMC Nephrol. 2018;19(1):1–11.CrossRef Verberne WR, Dijkers J, Kelder JC, Geers ABM, Jellema WT, Vincent HH, et al. Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: A cohort study. BMC Nephrol. 2018;19(1):1–11.CrossRef
Metadata
Title
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana
Authors
Perditer Okyere
Isaac Okyere
Grace Essuman
Joseph Attakora
Dorcas Serwaa
Irene Esi Donkoh
Richard K.D. Ephraim
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02951-z

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.